LPSN - LPSN INVESTOR ALERT: Robbins Geller Rudman & Dowd LLP Announces that LivePerson Inc. Investors with Substantial Losses Have Opportunity to Lead the LivePerson Class Action Lawsuit | Benzinga
SAN DIEGO, Dec. 01, 2023 (GLOBE NEWSWIRE) -- Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of LivePerson, Inc. (NASDAQ:LPSN) securities between May 10, 2022 and March 16, 2023, inclusive (the "Class Period"), have until January 30, 2024 to seek appointment as lead plaintiff of the LivePerson class action lawsuit. Captioned Damri v. LivePerson, Inc., No. 23-cv-10517 (S.D.N.Y.), the LivePerson class action lawsuit charges LivePerson and certain of its top executive officers with violations of the Securities Exchange Act of 1934.
If you suffered substantial losses and wish to serve as lead plaintiff of the LivePerson class action lawsuit, please provide your information here:
https://www.rgrdlaw.com/cases-liveperson-inc-class-action-lpsn.html
You can also contact attorney J.C. Sanchez of Robbins Geller by calling 800/449-4900 or via e-mail at jsanchez@rgrdlaw.com.
CASE ALLEGATIONS: LivePerson delivers mobile and online messaging solutions through Conversational Artificial Intelligence. In February 2022, LivePerson acquired WildHealth, Inc., a precision medicine service, according to the complaint. The complaint further alleges that in November 2022, unbeknownst to investors, WildHealth received notice that reimbursements for its services rendered under a Medicare demonstration program related to COVID-19 testing (the "Program") were suspended pending further review.
The LivePerson class action lawsuit alleges that defendants throughout the Class Period made false and/or misleading statements and/or failed to disclose that: (i) LivePerson's disclosure controls and procedures contained a material weakness; (ii) accordingly, LivePerson maintained deficient internal controls over its financial reporting; (iii) as a result, LivePerson's third quarter 2022 financial statements ...